Tue, June 15, 2010
Mon, June 14, 2010
Sat, June 12, 2010
Fri, June 11, 2010
Thu, June 10, 2010
Wed, June 9, 2010
Tue, June 8, 2010
Mon, June 7, 2010
Sun, June 6, 2010
Sat, June 5, 2010
Fri, June 4, 2010
Thu, June 3, 2010
Wed, June 2, 2010
Tue, June 1, 2010
[ Tue, Jun 01st 2010 ]: Market Wire
Covidien???????????????????
Mon, May 31, 2010
Sat, May 29, 2010
Fri, May 28, 2010

Cypress Bioscience, Inc. to Present at Jefferies 2010 Global Life Sciences Conference

  Copy link into your clipboard //health-fitness.news-articles.net/content/2010/ .. feries-2010-global-life-sciences-conference.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

SAN DIEGO, CA--(Marketwire - June 7, 2010) - Cypress Bioscience, Inc. (NASDAQ: [ CYPB ]) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Jefferies 2010 Global Life Sciences Conference on June 9, 2010.

The Jefferies conference is being held at the Grand Hyatt Hotel in New York, NY. Ms. Johnson is scheduled to present on Wednesday, June 9th at 10:30 am Eastern Time. The audio broadcast of this presentation can be accessed at [ http://www.wsw.com/webcast/jeff46/cypb/ ].

A replay of the presentation will be available at the same web address as well as on Cypress' website, [ http://www.cypressbio.com/events.php ].

About Cypress Bioscience
Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella® (milnacipran HCI) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at [ www.cypressbio.com ].